59084-06-9

Basic information

• Product Name: 1-(2-Nitrophenyl)piperazine
• Synonyms: 1-(2-NITROPHENYL)PIPERAZINE;Nitrophenylpiperazine;1-(2-Nitrophenyl)piperazine 98%;1-(2-Nitrophenyl)piperazine ,98%;1-(2-Nitrophenyl)piperazine ,92%;1-(2-Nitrophenyl)piperazine, 97.5%
• CAS NO: 59084-06-9
• Molecular Formula: C₁₀H₁₃N₃O₂
• Molecular Weight: 207.23
• EINECS: 261-593-1
• Product Categories: API intermediates
• Mol File: 59084-06-9.mol
• Article Data: 21

Chemical Properties

• Boiling Point: 142-144°C 1mm
• Flash Point: 177.4 °C
• Appearance: COA
• Density: 1.222 g/cm³
• Vapor Pressure: 1.17E-05mmHg at 25°C
• Refractive Index: 1.6080 to 1.6120
• PKA: 8.73±0.10(Predicted)
• CAS DataBase Reference: 1-(2-Nitrophenyl)piperazine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2-Nitrophenyl)piperazine(59084-06-9)
• EPA Substance Registry System: 1-(2-Nitrophenyl)piperazine(59084-06-9)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38-36
• Safety Statements: 26-36/37/39
• HazardClass: IRRITANT-HARMFUL
• Hazardous Substances Data: 59084-06-9(Hazardous Substances Data)

Usage

Chemical Properties

Yellow solid

InChI:InChI=1/C10H13N3O2/c14-13(15)10-4-2-1-3-9(10)12-7-5-11-6-8-12/h1-4,11H,5-8H2/p+1

Upstream product

• 170017-73-9 1-[1,1-Dimethylethoxycarbonyl]-4-(2-nitrophenyl)piperazine 
• 110-85-0 piperazine 
• 577-19-5 2-nitrophenyl bromide 
• 821-48-7 bis-(2-chloroethyl)amine hydrochloride 
• 88-74-4 2-nitro-aniline 
• 1493-27-2 ortho-nitrofluorobenzene 
• 88-73-3 2-Chloronitrobenzene 

Downstream Products

• 199105-16-3 1-benzyl-4-(2-nitrophenyl)piperazine 
• 630116-10-8 N-(3-methylphenyl)-2-[4-(2-nitrophenyl)-1-piperazinyl]acetamide 
• 13339-02-1 1-(2-aminophenyl)piperazine 
• 91703-27-4 5-[4-(2-nitrophenyl)piperazin-1-yl]pyrrolidin-2-one 
• 1259436-76-4 C₂₂H₂₄ClN₅O₂ 
• 1403353-55-8 C₁₇H₁₆N₆O₃ 
• 847238-08-8 (2-tert-butoxycarbonylamino-4-{2-[4-(2-nitro-phenyl)-piperazin-1-yl]-ethyl}-phenyl)-carbamic acid tert-butyl ester 
• 444583-81-7 1-(N-tert-butoxycarbonyl-D-Tic-4-Cl-D-Phe)-4-(2-nitrophenyl)piperazine 
• 170017-73-9 1-[1,1-Dimethylethoxycarbonyl]-4-(2-nitrophenyl)piperazine 
• 187110-10-7 1-(3-chloropropyl)-4-(2-nitrophenyl)piperazine 
• 203395-88-4 7-{4-[4-(2-Nitro-phenyl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-quinolin-2-one 

Relevant articles and documents

Synthesis and structure-activity relationships of new 2-phenoxybenzamides with antiplasmodial activity

The 2-phenoxybenzamide 1 from the Medicines for Malaria Venture Malaria Box Project has shown promising multi-stage activity against different strains of P. falciparum. It was successfully synthesized via a retrosynthetic approach. Subsequently, twenty-one new derivatives were prepared and tested for their in vitro activity against blood stages of the NF54 strain of P. falciparum. Several insights into structure-activity relationships were revealed. The antiplasmodial activity and cytotoxicity of compounds strongly depended on the substitution pattern of the anilino partial structure as well as on the size of substituents. The diaryl ether partial structure had further impacts on the activity. Additionally, several physicochemical and pharmacokinetic parameters were calculated (log P, log D7.4 and ligand efficiency) or determined experimentally (passive permeability and CYP3A4 inhibition). The tert-butyl-4-{4-[2-(4-fluorophenoxy)-3-(trifluoromethyl)benzamido]phenyl}piperazine-1-carboxylate possesses high antiplasmodial activity against P. falciparum NF54 (PfNF54 IC50 = 0.2690 μM) and very low cytotoxicity (L-6 cells IC50 = 124.0 μM) resulting in an excellent selectivity index of 460. Compared to the lead structure 1 the antiplasmodial activity was improved as well as the physicochemical and some pharmacokinetic parameters.

REGULATOR OF NITROGEN-CONTAINING HETEROAROMATIC DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF

The present invention relates to a regulator of nitrogen-containing heteroaromatic derivatives, a preparation method therefor and the use thereof. In particular, the present invention relates to a compound as shown in the general formula (I), a preparation method therefor and a pharmaceutical composition containing the compound, and the use thereof as a protein tyrosine phosphatase-2C (SHP2) inhibitor in the treatment of diseases or conditions such as leukemia, neuroblastoma, melanoma, breast cancer, lung cancer and colorectal cancer, wherein the definition of each substituent in the general formula (I) is the same as that in the description.

PYRROLE mTORC INHIBITORS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.